Skip to content
Cinematic 3D visualization of the stomach, intestines, liver and pancreas with warmly illuminated gut pathways.
Category

Gut & Digestion

Gastrointestinal, mucosal, pancreatic, and digestive signaling under study.

  • 25 research profiles
  • 14 peptides + 11 blends
  • Evidence review in progress

25 results

  • BPC + TB

    Blend · 2 components

    This blend is examined in studies of gastric, intestinal, and pancreatic pathways.

    • Gut & Digestion
    • Muscle & Recovery
    • + 3 more

    Published evidence — exact blend

    Not yet reviewed

    Components (reviewed separately)

    • BPCNR
    • TBNR
    Explore blend →
  • BPC 157 + GHK-Cu + TB-500

    Blend · 3 components

    This blend is examined in studies of gastric, intestinal, and pancreatic pathways.

    • Gut & Digestion
    • Muscle & Recovery
    • + 5 more

    Published evidence — exact blend

    Not yet reviewed

    Components (reviewed separately)

    • BPC 157NR
    • GHK-CuL4
    • TB-500NR
    Explore blend →
  • BPC 157 + GHK-Cu + TB-500 + KPV

    Blend · 4 components

    Research interest in this blend centres on gut-barrier integrity and digestive signaling.

    • Gut & Digestion
    • Muscle & Recovery
    • + 5 more

    Published evidence — exact blend

    Not yet reviewed

    Components (reviewed separately)

    • BPC 157NR
    • GHK-CuL4
    • TB-500NR
    • +1
    Explore blend →
  • This blend is examined in studies of gastric, intestinal, and pancreatic pathways.

    • Gut & Digestion
    • Muscle & Recovery
    • + 5 more

    Published evidence — exact blend

    Not yet reviewed

    Components (reviewed separately)

    • BPC-NR
    • TB-500(17-23)NR
    • GHK-Cu50mgNR
    • +1
    Explore blend →
  • BPC-157

    Individual peptide

    Research interest in BPC-157 centres on gut-barrier integrity and digestive signaling.

    • Gut & Digestion
    • Muscle & Recovery
    • Immune & Inflammation
    • +2 more

    Evidence level

    Level 2 · Animal Research

    Claim: Gastrointestinal and mucosal signaling

    1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established

    Extensive rodent studies; no completed controlled human trials.

    View evidence map →
    View profile →
  • Research interest in this blend centres on gut-barrier integrity and digestive signaling.

    • Gut & Digestion
    • Muscle & Recovery
    • + 5 more

    Published evidence — exact blend

    Not yet reviewed

    Components (reviewed separately)

    • BPC-157L2
    • GHK-Cu50mgNR
    • TB-500(17-23)NR
    Explore blend →
  • BPC-157 + TB-500(17-23)

    Blend · 2 components

    Researchers are studying this blend in relation to gastrointestinal signaling and mucosal pathways.

    • Gut & Digestion
    • Muscle & Recovery
    • + 3 more

    Published evidence — exact blend

    Not yet reviewed

    Components (reviewed separately)

    • BPC-157L2
    • TB-500(17-23)NR
    Explore blend →
  • Cagrilintide

    Individual peptide

    Cagrilintide is examined in studies of gastric, intestinal, and pancreatic pathways.

    • Gut & Digestion
    • Metabolism & Weight

    Evidence level

    Level 4 · Controlled Human Studies

    Claim: Gastrointestinal and mucosal signaling

    1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established

    Randomized controlled trials alone and with semaglutide.

    View evidence map →
    View profile →
  • Cagrilintide + Semaglutide

    Blend · 2 components

    Research interest in this blend centres on gut-barrier integrity and digestive signaling.

    • Gut & Digestion
    • Metabolism & Weight

    Published evidence — exact blend

    Not yet reviewed

    Components (reviewed separately)

    • CagrilintideL4
    • SemaglutideL5
    Explore blend →
  • Chonluten

    Individual peptide

    Chonluten is examined in studies of gastric, intestinal, and pancreatic pathways.

    • Gut & Digestion
    • Immune & Inflammation

    Evidence level

    Level 1 · Laboratory Research

    Claim: Gastrointestinal and mucosal signaling

    1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established

    Laboratory bioregulator work only.

    View evidence map →
    View profile →
  • Eloralintide

    Individual peptide

    Eloralintide is examined in studies of gastric, intestinal, and pancreatic pathways.

    • Gut & Digestion
    • Metabolism & Weight

    Evidence level

    Level 3 · Early Human Research

    Claim: Gastrointestinal and mucosal signaling

    1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established

    Early-phase human trials underway; no controlled outcome data published yet.

    View evidence map →
    View profile →
  • GHK-Cu100mg + KPV10mg

    Blend · 2 components

    Researchers are studying this blend in relation to gastrointestinal signaling and mucosal pathways.

    • Gut & Digestion
    • Cellular Energy
    • + 4 more

    Published evidence — exact blend

    Not yet reviewed

    Components (reviewed separately)

    • GHK-Cu100mgNR
    • KPV10mgNR
    Explore blend →
How evidence levels work

How to read the evidence

Every result card shows the same five-segment bar. Each level below matches the color of that segment.

  1. Level 1: Laboratory Research

    Observed in cells, tissue, or computational models only.

  2. Level 2: Animal Research

    Studied in animal models; results often do not transfer to people.

  3. Level 3: Early Human Research

    Human research

    Small, early-stage, or uncontrolled studies in humans.

  4. Level 4: Controlled Human Studies

    Human research

    Randomized or otherwise controlled human trials exist.

  5. Level 5: Regulatory Review or Established Clinical Use

    Human research

    Reviewed by a regulator or established in clinical practice for a specific use.

Evidence is rated by claim—not popularity. More studies do not always mean stronger evidence.

A higher level describes research maturity. It is not a recommendation or endorsement.

Educational information only. Not medical advice.

0 peptides selected

Select up to 6 peptides to compare.